Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double Matched Sibling HSCT for High-Risk Hematological Malignancies
NCT01385072Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Aug 2011
- Primary completion
- Aug 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of hematopoietic stem cells in acute leukemia, multiple myeloma (MM), lymphoma, sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
hematopoietic stem cells
03
Conditions
acute leukemiamultiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on NCT01385072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01385072.